mdi-book-open-variant Impressum mdi-help Hilfe / Anleitung mdi-printer Webseite ausdrucken mdi-bookmark Bookmark der Webseite speichern mdi-magnify Suche & Index Wirkstoffe mdi-sitemap Sitemap CliniPharm/CliniTox-Webserver mdi-home Startseite CliniPharm/CliniTox-Webserver mdi-email Beratungsdienst: Email / Post / Fax / Telefon

Wasfi IA, Al Ali WA, Agha BA, Kamel AM, Al Biriki NA et al
The pharmacokinetics and metabolism of meloxicam in camels after intravenous administration.

J Vet Pharmacol Ther, 35(2): 155-162, 2012
ISSN: 0140-7783 Journal of Veterinary Pharmacology and Therapeutics (PubMed)

Abstract
The pharmacokinetics and metabolism of meloxicam was studied in camels (Camelus dromedarus) (n = 6) following intravenous (i.v.) administration of a dose of 0.6 mgkg/body weight. The results obtained (mean SD) were as follows: the terminal elimination half-life (t(1/2)β) was 40.2 +/- 16.8 h and total body clearance (Cl(T) ) was 1.94 +/- 0.66 mL●kg/h. The volume of distribution at steady state (V(SS)) was 92.8 +/- 13.7 mL/kg. One metabolite of meloxicam was tentatively identified as methylhydroxy meloxicam. Meloxicam and metabolite were excreted unconjugated in urine. Meloxicam could be detected in plasma 10 days following i.v. administration in camels using a sensitive liquid chromatography tandem mass spectrometry (LC/MS/MS) method.

© 2021 - Institut für Veterinärpharmakologie und ‑toxikologie

Es kann keinerlei Haftung für Ansprüche übernommen werden, die aus dieser Webseite erwachsen könnten.